Continued enthusiasm for transcatheter aortic valve implantation (TAVI) with the Edwards’ Sapien device was tempered somewhat by poor outcomes observed in the group of patients for whom the procedure ...

Wilmington, Delaware and Munich, Germany – JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems ...

Transapical access is based on decades of clinical experience with de-airing the heart, through the tip (apex) of the left ventricle, during routine cardiac surgical interventions. Insertion of a ...

JenaValve, a German developer of transcatheter-delivered aortic valve systems, has received CE marking for its transapical trans-aortic valve implantation (TAVI) system comprised of the Cathlete ...

Transcatheter aortic valve implantation (TAVI) is now a viable therapeutic option for a wide variety of patients, through its numerous vascular access approaches and different valve systems The ...

October 2, 2008 (Lisbon, Portugal) — Surgeons testing the transapical delivery method for the Edwards Sapien transcatheter aortic valve say the latest results from pre- and postapproval studies in ...

The Engager ™ Aortic Valve Bioprosthesis (Medtronic, Minneapolis, MN, USA) is a new self-expanding valve prosthesis designed to be adaptable to the host's anatomy. A study conducted in three German ...

Please provide your email address to receive an email when new articles are posted on . In high-risk patients with predominant aortic regurgitation, transapical implantation of a new self-expandable ...

Please provide your email address to receive an email when new articles are posted on . Among patients with left ventricular dysfunction, transapical transcatheter aortic valve replacement conferred ...

Transcatheter aortic valve implantation (TAVI) aims to provide a less invasive alternative to open cardiac surgery for treating aortic stenosis, avoiding the need for sternotomy and cardiopulmonary ...